Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05354622

Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)

Sponsor: Boston Children's Hospital

View on ClinicalTrials.gov

Summary

The purpose of the HSP Sequencing Initiative is to better understand the role of genetics in hereditary spastic paraplegia (HSP) and related disorders. The HSPs are a group of more than 80 inherited neurological diseases that share the common feature of progressive spasticity. Collectively, the HSPs present the most common cause of inherited spasticity and associated disability, with a combined prevalence of 2-5 cases per 100,000 individuals worldwide. In childhood-onset forms, initial symptoms are often non-specific and many children may not receive a diagnosis until progressive features are recognized, often leading to a significant diagnostic delay. Genetic testing in children with spastic paraplegia is not yet standard practice. In this study, the investigators hope to identify genetic factors related to HSP. By identifying different genetic factors, the investigators hope that over time we can develop better treatments for sub-categories of HSP based on cause.

Official title: Investigating the Genetic Basis of Hereditary Spastic Paraplegia

Key Details

Gender

All

Age Range

1 Month - 30 Years

Study Type

OBSERVATIONAL

Enrollment

200

Start Date

2022-04-25

Completion Date

2027-04-29

Last Updated

2026-03-18

Healthy Volunteers

No

Locations (1)

Boston Children's Hospital

Boston, Massachusetts, United States